Company: GHRS
Filing Date: 2025-07-29
Form Type: 20-F/A
Source: 0001140361-25-027850
Chunk: 228

Company: GH Research PLC
Filing Date: 2025-07-29
Form: 20-F/A
Chunk 228
---
 Executive Officer                 |     |  50 |
| Magnus Halle            |     | Managing Director, Ireland              |     |  28 |
| Julie Ryan              |     | Vice President, Finance                 |     |  39 |
| Aaron Cameron           |     | Chief Operating Officer                 |     |  40 |
| Non-Executive Directors |     |                                         |     |     |
| Florian Schönharting    |     | Chairman of the Board of Directors      |     |  56 |
| Michael Forer           |     | Vice Chairman of the Board of Directors |     |  59 |
| Dermot Hanley           |     | Director                                |     |  60 |
| Duncan Moore            |     | Director                                |     |  65 |

Unless otherwise indicated, the current business address for our executive officers and our non-executive directors is GH Research PLC, Joshua Dawson House, Dawson Street, Dublin 2, D02 RY95, Ireland. 138 Table of Contents Executive Officers Velichka (Villy) Valcheva, MD, MSc,has served as our Chief Executive Officer since September 2024. Prior to this, Dr. Valcheva served as our Chief Medical Officer since February 2024 and Vice President of Clinical Research and Medical Affairs since August 2023. Dr. Valcheva has more than 20 years of experience in various leadership roles in pharmaceutical and biotech industries. Dr. Valcheva served as VP and Head of Medical Affairs International for Albireo from 2020 until 2023, as well as Medical Lead/Monitor FIH study and clinical development from 2022. Prior to this, Dr. Valcheva served as Global Senior Medical Director Oncology - Hepatocellular Carcinoma for Ipsen from 2018 to 2020. Dr. Valcheva holds a Masters in Pharmaceutical Medicine from Trinity College Dublin, Ireland, as well as a Dr. Med. from University of Medicine – Plovdiv, Bulgaria. Magnus Halle, has served as our Managing Director, Ireland since November 2020, is one of our co-founders, and served as a consultant to us from our founding in 2018 to 2020. Previously, Mr. Halle served as Analyst at NB Capital ApS, a position he held from 2018 to 2021. Additionally, from 2019, he served as the Money Laundering Reporting Officer at NB Capital Ap